US Stock MarketDetailed Quotes

ONTXW Onconova Therapeutics, Inc.

Watchlist
  • 0.000
  • 0.0000.00%
Close Nov 22 09:30 ET
0Market Cap0.00P/E (TTM)

Onconova Therapeutics, Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
(Q2)Jun 30, 2020
(Q1)Mar 31, 2020
(FY)Dec 31, 2019
(Q4)Dec 31, 2019
(Q3)Sep 30, 2019
(Q2)Jun 30, 2019
Total revenue
7.69%56K
-89.42%231K
90.00%57K
4.76%66K
-97.23%56K
-23.53%52K
77.77%2.18M
-49.15%30K
-47.50%63K
316.91%2.02M
Operating revenue
0.00%56K
-89.42%231K
90.00%57K
4.76%66K
-97.23%56K
-17.65%56K
77.77%2.18M
-49.15%30K
-47.50%63K
316.91%2.02M
Cost of revenue
Gross profit
Operating expense
-19.76%4.15M
5.62%25.22M
9.62%6.31M
22.84%6.34M
30.77%7.4M
-29.17%5.18M
-2.56%23.88M
-7.22%5.76M
-9.68%5.16M
-7.66%5.66M
Selling and administrative expenses
22.69%2.22M
-0.23%8.33M
3.92%1.78M
30.91%2.15M
47.39%2.59M
-44.12%1.81M
10.01%8.35M
-10.61%1.71M
-5.15%1.64M
-14.31%1.76M
-General and administrative expense
22.69%2.22M
-0.23%8.33M
3.92%1.78M
30.91%2.15M
47.39%2.59M
-44.12%1.81M
10.01%8.35M
-10.61%1.71M
-5.15%1.64M
-14.31%1.76M
Research and development costs
-42.52%1.94M
8.76%16.9M
12.03%4.53M
19.09%4.19M
23.26%4.8M
-17.30%3.37M
-8.20%15.54M
-5.71%4.05M
-11.64%3.52M
-4.30%3.9M
Operating profit
20.04%-4.1M
-15.18%-24.99M
-9.20%-6.26M
-23.07%-6.27M
-102.01%-7.34M
29.22%-5.13M
6.80%-21.7M
6.82%-5.73M
8.87%-5.1M
35.57%-3.63M
Net non-operating interest income expense
Other net income (expense)
-1,969.70%-617K
-177.67%-160K
-1,788.89%-170K
-93.44%33K
-177.78%-56K
109.19%33K
-92.50%206K
-102.42%-9K
104.47%503K
-94.54%72K
Gain on sale of security
-909.52%-636K
-430.16%-208K
-752.94%-145K
-88.24%56K
-275.00%-56K
85.25%-63K
-96.06%63K
-111.89%-17K
268.99%476K
-93.76%32K
Other non- operating income (expenses)
-80.21%19K
-66.43%48K
-412.50%-25K
-185.19%-23K
----
41.18%96K
-87.58%143K
-99.13%8K
-76.92%27K
-64.29%40K
Income before tax
7.40%-4.72M
-17.03%-25.15M
-11.99%-6.43M
-35.82%-6.24M
-107.67%-7.4M
33.00%-5.09M
-4.67%-21.49M
0.66%-5.74M
14.08%-4.6M
17.59%-3.56M
Income tax
-60.00%4K
108.06%10K
Net income
7.40%-4.72M
-16.99%-25.16M
-11.87%-6.43M
-35.82%-6.24M
-107.67%-7.4M
33.00%-5.09M
-5.36%-21.5M
-1.70%-5.75M
14.08%-4.6M
17.59%-3.56M
Net income continuous Operations
7.40%-4.72M
-16.99%-25.16M
-11.87%-6.43M
-35.82%-6.24M
-107.67%-7.4M
33.00%-5.09M
-5.36%-21.5M
-1.70%-5.75M
14.08%-4.6M
17.59%-3.56M
Minority interest income
Net income attributable to the parent company
7.40%-4.72M
-16.99%-25.16M
-11.87%-6.43M
-35.82%-6.24M
-107.67%-7.4M
33.00%-5.09M
-4.52%-21.5M
-1.70%-5.75M
14.08%-4.6M
20.58%-3.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
7.40%-4.72M
-16.99%-25.16M
-11.87%-6.43M
-35.82%-6.24M
-107.67%-7.4M
33.00%-5.09M
-4.52%-21.5M
-1.70%-5.75M
14.08%-4.6M
20.58%-3.56M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020(Q2)Jun 30, 2020(Q1)Mar 31, 2020(FY)Dec 31, 2019(Q4)Dec 31, 2019(Q3)Sep 30, 2019(Q2)Jun 30, 2019
Total revenue 7.69%56K-89.42%231K90.00%57K4.76%66K-97.23%56K-23.53%52K77.77%2.18M-49.15%30K-47.50%63K316.91%2.02M
Operating revenue 0.00%56K-89.42%231K90.00%57K4.76%66K-97.23%56K-17.65%56K77.77%2.18M-49.15%30K-47.50%63K316.91%2.02M
Cost of revenue
Gross profit
Operating expense -19.76%4.15M5.62%25.22M9.62%6.31M22.84%6.34M30.77%7.4M-29.17%5.18M-2.56%23.88M-7.22%5.76M-9.68%5.16M-7.66%5.66M
Selling and administrative expenses 22.69%2.22M-0.23%8.33M3.92%1.78M30.91%2.15M47.39%2.59M-44.12%1.81M10.01%8.35M-10.61%1.71M-5.15%1.64M-14.31%1.76M
-General and administrative expense 22.69%2.22M-0.23%8.33M3.92%1.78M30.91%2.15M47.39%2.59M-44.12%1.81M10.01%8.35M-10.61%1.71M-5.15%1.64M-14.31%1.76M
Research and development costs -42.52%1.94M8.76%16.9M12.03%4.53M19.09%4.19M23.26%4.8M-17.30%3.37M-8.20%15.54M-5.71%4.05M-11.64%3.52M-4.30%3.9M
Operating profit 20.04%-4.1M-15.18%-24.99M-9.20%-6.26M-23.07%-6.27M-102.01%-7.34M29.22%-5.13M6.80%-21.7M6.82%-5.73M8.87%-5.1M35.57%-3.63M
Net non-operating interest income expense
Other net income (expense) -1,969.70%-617K-177.67%-160K-1,788.89%-170K-93.44%33K-177.78%-56K109.19%33K-92.50%206K-102.42%-9K104.47%503K-94.54%72K
Gain on sale of security -909.52%-636K-430.16%-208K-752.94%-145K-88.24%56K-275.00%-56K85.25%-63K-96.06%63K-111.89%-17K268.99%476K-93.76%32K
Other non- operating income (expenses) -80.21%19K-66.43%48K-412.50%-25K-185.19%-23K----41.18%96K-87.58%143K-99.13%8K-76.92%27K-64.29%40K
Income before tax 7.40%-4.72M-17.03%-25.15M-11.99%-6.43M-35.82%-6.24M-107.67%-7.4M33.00%-5.09M-4.67%-21.49M0.66%-5.74M14.08%-4.6M17.59%-3.56M
Income tax -60.00%4K108.06%10K
Net income 7.40%-4.72M-16.99%-25.16M-11.87%-6.43M-35.82%-6.24M-107.67%-7.4M33.00%-5.09M-5.36%-21.5M-1.70%-5.75M14.08%-4.6M17.59%-3.56M
Net income continuous Operations 7.40%-4.72M-16.99%-25.16M-11.87%-6.43M-35.82%-6.24M-107.67%-7.4M33.00%-5.09M-5.36%-21.5M-1.70%-5.75M14.08%-4.6M17.59%-3.56M
Minority interest income
Net income attributable to the parent company 7.40%-4.72M-16.99%-25.16M-11.87%-6.43M-35.82%-6.24M-107.67%-7.4M33.00%-5.09M-4.52%-21.5M-1.70%-5.75M14.08%-4.6M20.58%-3.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 7.40%-4.72M-16.99%-25.16M-11.87%-6.43M-35.82%-6.24M-107.67%-7.4M33.00%-5.09M-4.52%-21.5M-1.70%-5.75M14.08%-4.6M20.58%-3.56M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data